# Abvc Biopharma, Inc.: Form SCHEDULE 13D/A, filed Jul 15, 2025

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: SCHEDULE 13D/A
- Filed: 2025-07-15
- Accepted by EDGAR: Jul 15, 2025, 16:30 ET
- Period: not reported
- Accession: 0001213900-25-064283
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025064283/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390025064283/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390025064283/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jul 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-064283. Last ingested by Listed: Nov 14, 2026, 21:07 ET. No prices; not investment advice.
